Cardiovascular effects of farnesol and its β-cyclodextrin complex in normotensive and hypertensive rats-Reference-Cited by-同舟云学术

Cardiovascular effects of farnesol and its β-cyclodextrin complex in normotensive and hypertensive rats

Published:2021-06 Issue: Volume:901 Page:174060
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Silva Eric Aian P.,Carvalho Jéssica S.,dos Santos Danillo M.,Oliveira Ana Maria S.,de Souza Araújo Adriano A.,Serafini Mairim R.,Oliveira Santos Lucas A.B.,Batista Marcus V. de A.^ORCID,Viana Santos Márcio R.,Siqueira Quintans Jullyana de S.,Quintans-Júnior Lucindo J.,Barreto André S.

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Elsevier BV

Subject

Pharmacology

Reference111 articles.

1. Drugs–β-Cyclodextrin inclusion complex: would be a new strategy to improve Antihypertensive Therapy?;Alves;Clin Res Trial,2019

2. Protective effects of terpenes on the cardiovascular system: current advances and future perspectives;Alves-Silva;Curr. Med. Chem.,2016

3. Antihypertensive therapeutic potential of citronellal;Andrade;Lat. Am. J. Pharm.,2012

4. Cardiovascular effects induced by linalool in normotensive and hypertensive rats;Anjos;Z. Naturforsch. C Biosci.,2013

5. A molecular docking approach to evaluate the pharmacological properties of natural and synthetic treatment candidates for use against hypertension;Attique;IJERPH,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Technological trends in cyclodextrin inclusion complexes for improving cardiovascular drug therapy: A patent review;Journal of Drug Delivery Science and Technology;2024-11

2. Measurement of blood pressure in rats: Invasive or noninvasive methods?;Physiological Reports;2024-09

3. Unravelling therapeutic potential and nano formulation approaches of farnesol, a bioactive sesquiterpene;Advances in Traditional Medicine;2024-06-23

4. Farnesol as a multifunctional candidate for treatment development;BIOCELL;2024

5. Vasorelaxant effect of (E,E)-farnesol in human umbilical vein ex vivo assays;Chemico-Biological Interactions;2023-12